These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial. Roberts JD; Wells GA; Le May MR; Labinaz M; Glover C; Froeschl M; Dick A; Marquis JF; O'Brien E; Goncalves S; Druce I; Stewart A; Gollob MH; So DY Lancet; 2012 May; 379(9827):1705-11. PubMed ID: 22464343 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision Medicine. Rakicevic L; Nestorovic A Clin Pharmacol Ther; 2019 Mar; 105(3):547-549. PubMed ID: 29920652 [TBL] [Abstract][Full Text] [Related]
4. Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach. Lin G; Yi L; Zhang K; Wang L; Zhang R; Xie J; Li J PLoS One; 2015; 10(7):e0134174. PubMed ID: 26218263 [TBL] [Abstract][Full Text] [Related]
5. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice. Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317 [No Abstract] [Full Text] [Related]
6. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines]. Hafner S; Haubensak S; Paul T; Zolk O Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332 [No Abstract] [Full Text] [Related]
7. The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19. Yang Y; Lewis JP; Hulot JS; Scott SA Expert Opin Drug Metab Toxicol; 2015; 11(10):1599-617. PubMed ID: 26173871 [TBL] [Abstract][Full Text] [Related]
9. A pharmacodynamic comparison of a personalized strategy for anti-platelet therapy versus ticagrelor in achieving a therapeutic window. Malhotra N; Abunassar J; Wells GA; McPherson R; Fu A; Hibbert B; Labinaz M; Le May M; Dick A; Glover C; Froeschl M; Marquis JF; Tran L; Bernick J; Chong AY; So DY; Int J Cardiol; 2015 Oct; 197():318-25. PubMed ID: 26151596 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of clopidogrel: evidence and perspectives. Yin T; Miyata T Thromb Res; 2011 Oct; 128(4):307-16. PubMed ID: 21592545 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics: Using Genetic Information to Guide Drug Therapy. Chang KL; Weitzel K; Schmidt S Am Fam Physician; 2015 Oct; 92(7):588-94. PubMed ID: 26447442 [TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics: from discovery to patient care. Shin J; Kayser SR; Langaee TY Am J Health Syst Pharm; 2009 Apr; 66(7):625-37. PubMed ID: 19299369 [TBL] [Abstract][Full Text] [Related]
13. Genetic testing for pharmacogenetics and its clinical application in drug therapy. Hiratsuka M; Sasaki T; Mizugaki M Clin Chim Acta; 2006 Jan; 363(1-2):177-86. PubMed ID: 16126184 [TBL] [Abstract][Full Text] [Related]
14. Most Recent Evidence Behind Aggregometry and Genotyping Methods as Platelet Function Testing for Tailored Anti-Platelet Treatment Among PCI Patients. Gajda SN; Kołtowski Ł; Tomaniak M Adv Clin Exp Med; 2015; 24(4):687-93. PubMed ID: 26469115 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin. George J; Doney A; Palmer CN; Lang CC Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312 [No Abstract] [Full Text] [Related]
16. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205 [TBL] [Abstract][Full Text] [Related]
17. Personalizing medicine with clinical pharmacogenetics. Scott SA Genet Med; 2011 Dec; 13(12):987-95. PubMed ID: 22095251 [TBL] [Abstract][Full Text] [Related]
18. Impact of CYP2C19 genetic testing on provider prescribing patterns for antiplatelet therapy after acute coronary syndromes and percutaneous coronary intervention. Desai NR; Canestaro WJ; Kyrychenko P; Chaplin D; Martell LA; Brennan T; Matlin OS; Choudhry NK Circ Cardiovasc Qual Outcomes; 2013 Nov; 6(6):694-9. PubMed ID: 24192573 [TBL] [Abstract][Full Text] [Related]
19. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice]. Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424 [TBL] [Abstract][Full Text] [Related]
20. Diversity of platelet function and genetic polymorphism in clopidogrel-treated Chinese patients. Sun B; Li J; Dong M; Yang L; Wu C; Zhu L; Cong YL Genet Mol Res; 2015 Feb; 14(1):1434-42. PubMed ID: 25730082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]